Literature DB >> 9067545

Manganese superoxide dismutase expression inhibits soft agar growth in JB6 clone41 mouse epidermal cells.

P A Amstad1, H Liu, M Ichimiya, I K Berezesky, B F Trump.   

Abstract

Manganese superoxide dismutase (MnSOD) has been found to be depleted in a variety of tumor cells as well as in in vitro transformed cell lines, suggesting that MnSOD may function as an anticarcinogen by protecting the cell from oxidant-induced carcinogenesis. The relationship between MnSOD expression and tumor promotion was studied by transfection of a human MnSOD cDNA into the promotable mouse epidermal cell line JB6 clone41. The effect of MnSOD overexpression on the promotion-sensitive phenotype of JB6 cells was assessed by measuring growth characteristics such as growth rate and the ability to form colonies in soft agar. Compared with the parental and vector-transfected (gpt) control cells, MnSOD-overexpressing cells had a slower growth rate and their ability to form colonies in soft agar was significantly decreased in response to 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment. Since the transformation-sensitive phenotype of JB6 clone41 cells is associated with increased expression of the transcription factor AP-1, we compared c-jun and c-fos mRNA expression in MnSOD-transfected and control JB6 cells. Overexpression of MnSOD led to a significant decrease in c-jun and c-fos expression in response to treatment with TPA or the oxidant promoter superoxide. These findings indicate that the promotion-sensitive phenotype of JB6 clone41 cells can be reverted by increasing MnSOD intracellularly. A possible mechanism is that elevated MnSOD expression might change the intracellular redox state by altering the balance of reactive oxygen species. This could lead to a modulation of TPA and oxidant-induced signal transduction pathways controlling cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067545     DOI: 10.1093/carcin/18.3.479

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

Review 1.  Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis.

Authors:  Joydeb Kumar Kundu; Young-Joon Surh
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

2.  Distinct functions of CCAAT enhancer-binding protein isoforms in the regulation of manganese superoxide dismutase during interleukin-1beta stimulation.

Authors:  Xiaolei Qiu; Kimberly J Aiken; Ann L Chokas; Dawn E Beachy; Harry S Nick
Journal:  J Biol Chem       Date:  2008-06-17       Impact factor: 5.157

3.  Mitochondrial Electron Transport Chain-Derived Superoxide Exits Macrophages: Implications for Mononuclear Cell-Mediated Pathophysiological Processes.

Authors:  Yunbo Li; Hong Zhu; Periannan Kuppusamy; Jay L Zweier; Michael A Trush
Journal:  React Oxyg Species (Apex)       Date:  2016

Review 4.  The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive.

Authors:  Arindam Dhar; Mathew R Young; Nancy H Colburn
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

5.  All-trans-retinoic acid induces manganese superoxide dismutase in human neuroblastoma through NF-kappaB.

Authors:  Kinsley K Kiningham; Zina-Ann Cardozo; Carla Cook; Marsha P Cole; John C Stewart; Mariela Tassone; Mitchell C Coleman; Douglas R Spitz
Journal:  Free Radic Biol Med       Date:  2008-01-30       Impact factor: 7.376

6.  JP-8 induces immune suppression via a reactive oxygen species NF-kappabeta-dependent mechanism.

Authors:  Gerardo Ramos; Alberto Y Limon-Flores; Stephen E Ullrich
Journal:  Toxicol Sci       Date:  2008-12-18       Impact factor: 4.849

7.  Association of alanine-valine manganese superoxide dismutase gene polymorphism and microheterogeneity manganese superoxide dismutase activity in breast cancer and benign breast tissue.

Authors:  Manar Atoum; Malak Abdel-Fattah; Nisreen Nimer; Saleem Abdel-Rahman; Sawsan A Abdeldayem
Journal:  J Breast Cancer       Date:  2012-06-28       Impact factor: 3.588

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.